Vitamin D, 25-Hydroxy
| Vitamin D, 25-Hydroxy | | | |
| Number | | 081950 |
| CPT | | 82306 |
| Synonyms | | Cholecalciferol Metabolite ; 25-Hydroxycalciferol ; 25-OH-D ; Vitamin D3 Metabolite |
| Special Instructions | | This is not the same as calcitriol or 1,25 dihydroxy vitamin D3. Calcitriol must be ordered separately. |
| Specimen | | Serum or plasma |
| Volume | | 0.5 mL |
| Minimum Volume | | 0.3 mL (Note: This volume does not allow for repeat testing.) |
Container | | Red-top tube, gel-barrier tube, or lavender-top (EDTA) tube |
| Collection | | If tube other than a gel-barrier tube is used, transfer separated serum or plasma to a plastic transport tube. |
| Storage Instructions | | Refrigerate |
Causes for Rejection | | Heparin plasma (green-top tube) |
| Reference Interval | | 32-100 ng/mL. Recent studies consider the lower limit of
32.0 ng/mL to be a threshold for optimal
health.1 |
| Use | | Rule out vitamin D deficiency |
| Limitations | | Values of vitamin D vary with exposure to sunlight. There
are also variations during the menstrual cycle, particularly
at the time of ovulation. The assay measures other vitamin D
metabolites including dihydroxylated metabolites such as
24,25, 25,26, and 1,25 dihydroxy vitamin D; however, since
the physiological concentrations of these metabolites are
insignificant compared to those of 25-hydroxy vitamin D, the
accuracy in assessing vitamin D levels is not compromised. |
| Methodology | | Immunochemiluminometric assay (ICMA). This assay is
performed on the DiaSorin LIAISON® instrument
in multiple laboratories throughout LabCorp. This highly
automated test measures both D2 and D3
together and reports a total 25-hydroxy vitamin D. Major
clinical studies, including (but not limited to) the Centers
for Disease Control (CDC) National Health and Nutrition
Examination Survey (NHANES) data base, the Women's Health
Initiative (WHI) studies, and the Harvard-based Health
Professionals Studies, employed DiaSorin reagents. |
| Additional Information | | The majority of 25-OH vitamin D (25-D) in the circulation is
derived from the conversion of 7-dehydrocholesterol in the
skin that is irradiated with ultraviolet radiation in the
UVB range (wavelength 290 nm to 315 nm).2-4 The
extent of vitamin D formation is not tightly controlled and
depends primarily on the duration and intensity of the UV
irradiation. Levels produced typically reach a plateau
within 30 minutes of exposure.4 Unfortunately,
use of a sunscreen with SPF as low as 15 reduces the rate of
vitamin D production by 99.9%.2 Overproduction of
vitamin D in the skin is prevented by the photosensitive
conversion of vitamin D to tachysterol or
lumisterol.4 Vitamin D is not very water-soluble,
so it must be delivered to and carried in the blood as a
complex with vitamin D-binding protein.3,4 Once
in the circulation, vitamin D is metabolized to 25-hydroxy
vitamin D(25-D) by the liver.3,4 The 25-D form of
the hormone is the principle circulating reservoir in plasma
and is generally the best indicator of overall vitamin D
status.4 25-D is further metabolized by the
kidney to produce the biologically-active form of vitamin D,
1,25-dihydroxy vitamin D (1,25-D).3,4 Renal
production of 1,25-D is tightly controlled by parathyroid
hormone and is important in the regulation of serum calcium
homeostasis.4 The hormonally-active form of
vitamin D,1,25-D plays an integral role in calcium
homeostasis and in the maintenance of healthy
bone.2,3,5 1,25-D stimulates the absorption of
calcium at the level of the intestine and may also serve to
increase calcium and phosphate resorption at the kidney
level.3 Vitamin D deficiency leads to the
mobilization of calcium from bone.4 Individuals
with more severe vitamin D deficiency can develop
osteomalacia and/or osteoporosis.2 Osteomalacia
in children, also referred to as rickets, results in well
described skeletal malformations since their bones are
actively growing.2 Recent clinical and
epidemiological studies suggest that vitamin D deficiency
may play a role in several conditions unrelated to bone
including prostate cancer, breast cancer, colon cancer,
heart disease, hypertension, multiple sclerosis, and type 1
diabetes.2,4,5 A number of studies have
shown that vitamin D deficiency is very common, especially
in certain high-risk populations.2 This situation
has occurred, in part, because the foods in the typical
American diet are very low in vitamin D. Fatty fish, such as
mackeral and salmon and fish liver oils, are some of the few
natural dietary sources of vitamin D.2-5 Most
people do not eat enough of these foods to maintain adequate
vitamin D levels. In the United States, vitamin D is added
to milk in order to prevent the occurrence of rickets in the
pediatric population. Unfortunately, too many children do
not drink enough milk to raise their vitamin D levels to the
optimum range. Also, recent studies have shown that the
level of vitamin D in fortified milk is frequently much
lower than that recommended by the FDA.2 Human
milk contains very little vitamin D because many mothers are
deficient, so children of mothers who choose to breast-feed
are at risk of developing rickets if they are not given
supplemental vitamin D. The American Academy of Pediatrics
recommends that infants who are exclusively breast-feeding
should be given a supplement of vitamin D.6
Several factors are associated with an increased risk
of developing vitamin D deficiency. At risk populations
include2-4: - Individuals with low
dietary vitamin D levels: Infants fed only mother's milk and
children who do not drink fortified milk are at risk.
- Individuals with malabsorption syndromes: Patients
with pancreatic enzyme deficiency, Crohn's disease, cystic
fibrosis, celiac disease, and surgical resection of stomach
or intestines are at risk.
- Individuals with severe
liver disease: Hepatic disease can reduce the conversion of
vitamin D to 25-D and can lead to malabsorption of vitamin
D.
- Individuals with kidney disease: Nephrotic
syndrome can increase the urinary loss of vitamin D.
- Individuals taking certain drugs: Several
medications, including phenytoin, phenobarbital, and
rifampin accelerate the breakdown of vitamin D by the liver.
- Individuals who live at higher latitudes:
Individuals who live in northern climates are at increased
risk of deficiency, especially in winter months due to
diminished exposure to UVB radiation.
- Individuals
who spend little time outside: Individuals who are
home-bound or simply choose to remain inside are at
increased risk.
- Older adults: The skin becomes
less efficient at producing vitamin D as one ages because of
diminished levels of vitamin D precursors in the skin.
- Individuals with decreased sun exposure for
cultural reasons: Women in some societies are required to
cover themselves with heavy clothing, reducing exposure to
the sun's rays.
- Races with high melanin levels:
Increased skin pigmentation can reduce the efficiency of
vitamin D conversion in the skin as much as 50-fold.
Individuals with dark complexions living at higher latitudes
are at increased risk.
Serum concentrations of
25-D are known to vary with age, sex, race, season, and
geographic location.2 This has led to establish
seasonal expected ranges for the geographic location and
local population. This approach provides a “reference
interval,” but does not adequately determine health status
with regard to vitamin D levels if a significant portion of
the reference population is, in fact, deficient. A more
useful parameter in clinical practice would be a nutritional
threshold, below which an individual could be characterized
as vitamin D deficient. Several investigators have
approached this problem by assessing the correlation of
plasma 25-D concentration with various biological
markers.1 For example, plasma 25-D levels have
been shown to have an inverse relationship to serum
parathyroid hormone levels.1 Secondary
hyperparathyroidism can be corrected when 25-D levels are
increased to >32 ng/mL (80 nmol/L).1 Serum
concentrations <32 ng/mL have been shown to impair
intestinal calcium absorption and subsequent skeletal
density.1 Further studies have shown that 25-D
levels <32 ng/mL are associated with impaired insulin
resistance and beta-cell function.1 Together
these data suggest that 32 ng/mL represents the appropriate
threshold for identifying individuals with clinical vitamin
D deficiency.1 |
| Footnotes | | - Hollis BW, “Circulating 25-Hydroxyvitamin D Levels Indicative of Vitamin D Sufficiency; Implications for Establishing a New Effective Dietary Intake Recommendation for Vitamin D,” J Nutr, 2005, 135(2):317-22.
- Holick MF and Jenkins M, The UV Advantage: The Medical Breakthrough That Shows How to Harness the Power of the Sun for Your Health, New York, NY: ibooks, 2003.
- Endres DB and Rude RK, “Mineral and Bone Metabolism,” Tietz Textbook of Clinical Chemistry, 3rd ed, Burtis CA and Ashwood ER, eds, Philadelphia, PA: WB Saunders, 1999, 1395-457.
- Zitterman A, “Vitamin D in Preventive Medicine: Are We Ignoring the Evidence?” Br J Nutr, 2003, 89(5):552-72.
- Holick MF, “Vitamin D: A Millenium Perspective,” J Cell Biochem, 2003, 88(2):296-307.
- National Institute of Health, Office of Dietary Supplement Fact Sheet: Vitamin D. http://ods/od/nih/gov. Accessed 07/14/2004
|
| References | | Heaney RP and Weaver CM, “Calcium and Vitamin D,” Endocrinol Metab Clin North Am, 2003, 32(1):181-94, vii-viii. |
|